Apeiron Investment Group Ltd. - Jul 14, 2022 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: 10%+ Owner
Signature: Apeiron Investment Group Ltd., By: /s/ Julien Hofer, Director
Stock symbol: SNSE
Transactions as of: Jul 14, 2022
Transactions value $: $0
Form type: 3
Date filed: 7/20/2022, 09:53 AM
Previous filing: May 2, 2022
Next filing: Feb 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SNSE	Common Stock						2.48M	Jul 14, 2022	By Apeiron Investment Group Ltd.	F1
holding	SNSE	Common Stock						956K	Jul 14, 2022	By Presight Sensei Co-Invest Fund, L.P.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The general partner of Presight Sensei Co-Invest Fund, L.P. is Presight Sensei Co-Invest Management, L.L.C., which is a wholly owned subsidiary of Apeiron Investment Group, Ltd. As a result, each of Apeiron Investment Group, Ltd. and Presight Sensei Co-Invest Management, L.L.C. may be deemed to share beneficial ownership of the securities held by Presight Sensei Co-Invest Fund, L.P. Christian Angermayer is the majority shareholder of Apeiron and may be deemed to share beneficial ownership of the securities beneficially owned by Apeiron.

Content

The general partner of Presight Sensei Co-Invest Fund, L.P. is Presight Sensei Co-Invest Management, L.L.C., which is a wholly owned subsidiary of Apeiron Investment Group, Ltd. As a result, each of Apeiron Investment Group, Ltd. and Presight Sensei Co-Invest Management, L.L.C. may be deemed to share beneficial ownership of the securities held by Presight Sensei Co-Invest Fund, L.P. Christian Angermayer is the majority shareholder of Apeiron and may be deemed to share beneficial ownership of the securities beneficially owned by Apeiron.